EUVIMEDEUVIMED entdecken
Crossref

Bioinspired platelet membrane-cloaked ROS-responsive nanozymes enable synergistic therapy of acute kidney injury via immunomodulation and ferroptosis suppression

Dongjing Wang, Xiaonan Li, Kunpeng Wei, Suyan Wang, Wen Zuo, Ze Xu, Chen Li, Hui Wang, Xueyan Zhou, Yanzhuo Zhang

Journal of Controlled Release · 2026

DOI: 10.1016/j.jconrel.2026.115191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026. Verfasst von Dongjing Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Reactive Oxygen Species, Cerium, Flavanones. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Jiangsu Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute kidney injury (AKI) is a prevalent clinical syndrome associated with high morbidity, mortality, and a heavy medical burden. Oxidative stress, inflammation, and ferroptosis are key drivers of AKI, yet current pharmacotherapies are limited by suboptimal efficacy and systemic side effects. An efficient and precise kidney-targeted delivery system that co-delivers complementary therapeutics could overcome these challenges. Herein, we report a platelet membrane-coated, reactive oxygen species (ROS)-responsive nanozyme (BAPCs@PM) for synergistic AKI therapy. Ultrasmall CeO2 nanodots (∼3 nm) were in situ mineralized on the outer layer of polydopamine cores, and hydrophobic baicalein was loaded into the mesoporous interior, yielding a stable and well-dispersed multifunctional composite nanozyme. Platelet membrane cloaking conferred renal targeting, immune evasion, and prolonged circulation. BAPCs@PM enabled ROS-triggered release of CeO2 nanodots and sustained baicalein delivery at injured sites, amplifying local antioxidant, anti-inflammatory, and anti-ferroptotic activity. In a cisplatin-induced AKI model, BAPCs@PM markedly suppressed kidney injury molecule-1 upregulation, inhibited cleaved caspase-3 activation and apoptosis, enhanced mitochondrial protection, modulated macrophage polarization, reduced proinflammatory cytokine production, regulated iron homeostasis, restored glutathione peroxidase 4 expression, attenuated ferroptosis and lipid peroxidation, and ultimately improved renal function. Owing to their ultrasmall size, the ceria nanodots achieved efficient renal accumulation and rapid clearance with minimal systemic toxicity. This study provides an innovative biomimetic and responsive therapeutic strategy for AKI by combining ultrasmall nanozymes, natural bioactive molecules, and biomimetic membrane engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryReactive Oxygen SpeciesCeriumFlavanonesBlood PlateletsNanoparticlesAnimalsFerroptosisMaleMicePolymersCisplatinIndolesMice, Inbred C57BLAntioxidants

Stichwörter der Autor:innen

Acute kidney injuryBiomimetic nanoplatformComposite nanozymeOxidative stressTargeted delivery

Substanzen

Reactive Oxygen SpeciesCeriumbaicaleinFlavanonesceric oxidePolymersCisplatinIndolespolydopamineAntioxidants

Autor:innen und Institutionen

  • School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing 211100, China.
  • Department of Pharmacy, Xuzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Xuzhou, Jiangsu 221009, China.
  • Department of Pharmacy, Xuzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Xuzhou, Jiangsu 221009, China. Electronic address: xzzyywh@163.com.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China. Electronic address: zxy851107@xzhmu.edu.cn.
  • School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China. Electronic address: yanzhuozhang@xzhmu.edu.cn.

Förderung

  • Jiangsu Province Natural Science Foundation

Zitieren

APA

Wang, D., Li, X., Wei, K., Wang, S., Zuo, W., Xu, Z., Li, C., Wang, H., Zhou, X., & Zhang, Y. (2026). Bioinspired platelet membrane-cloaked ROS-responsive nanozymes enable synergistic therapy of acute kidney injury via immunomodulation and ferroptosis suppression. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115191

Vancouver

Wang D, Li X, Wei K, Wang S, Zuo W, Xu Z, et al. Bioinspired platelet membrane-cloaked ROS-responsive nanozymes enable synergistic therapy of acute kidney injury via immunomodulation and ferroptosis suppression. Journal of Controlled Release. 2026. doi:10.1016/j.jconrel.2026.115191

BibTeX
@article{Wang2026,
  author = {Wang, Dongjing and Li, Xiaonan and Wei, Kunpeng and Wang, Suyan and Zuo, Wen and Xu, Ze and Li, Chen and Wang, Hui and Zhou, Xueyan and Zhang, Yanzhuo},
  title = {Bioinspired platelet membrane-cloaked ROS-responsive nanozymes enable synergistic therapy of acute kidney injury via immunomodulation and ferroptosis suppression},
  journal = {Journal of Controlled Release},
  year = {2026},
  doi = {10.1016/j.jconrel.2026.115191}
}
Kostenlos starten →